Explore

Trendline Trendline
Freeport-McMoRan Faces Securities Fraud Class Action Over Safety Issues

Freeport-McMoRan Faces Securities Fraud Class Action Over Safety Issues

Freeport-McMoRan Faces Securities Fraud Class Action Over Safety Issues
Trendline Trendline
Nick McDonald Joins Marks Clerk as Partner to Enhance IP Services

Nick McDonald Joins Marks Clerk as Partner to Enhance IP Services

Nick McDonald Joins Marks Clerk as Partner to Enhance IP Services
Trendline Trendline
Blue Owl Capital Faces Securities Fraud Lawsuit Led by Schall Law Firm

Blue Owl Capital Faces Securities Fraud Lawsuit Led by Schall Law Firm

Blue Owl Capital Faces Securities Fraud Lawsuit Led by Schall Law Firm
Trendline Trendline
Firefly Aerospace Faces Class Action Lawsuit Over Alleged Misleading Statements

Firefly Aerospace Faces Class Action Lawsuit Over Alleged Misleading Statements

Firefly Aerospace Faces Class Action Lawsuit Over Alleged Misleading Statements
Trendline Trendline
Faruqi Faruqi Alerts Skye Investors on Class Action Lawsuit Deadline

Faruqi Faruqi Alerts Skye Investors on Class Action Lawsuit Deadline

Faruqi Faruqi Alerts Skye Investors on Class Action Lawsuit Deadline
Trendline Trendline
Ardent Health Faces Securities Fraud Investigation by Schall Law Firm Following Financial Disclosures

Ardent Health Faces Securities Fraud Investigation by Schall Law Firm Following Financial Disclosures

Ardent Health Faces Securities Fraud Investigation by Schall Law Firm Following Financial Disclosures
Trendline Trendline
Faruqi Faruqi Alerts Stride Investors to Class Action Lawsuit with January 2026 Deadline

Faruqi Faruqi Alerts Stride Investors to Class Action Lawsuit with January 2026 Deadline

Faruqi Faruqi Alerts Stride Investors to Class Action Lawsuit with January 2026 Deadline
Trendline Trendline
Forescout Technologies Settles Securities Fraud Claims for $45 Million

Forescout Technologies Settles Securities Fraud Claims for $45 Million

Forescout Technologies Settles Securities Fraud Claims for $45 Million
Trendline Trendline
DexCom Faces Securities Fraud Class Action Over Alleged Misleading Statements

DexCom Faces Securities Fraud Class Action Over Alleged Misleading Statements

DexCom Faces Securities Fraud Class Action Over Alleged Misleading Statements
Trendline Trendline
Arrowhead Pharmaceuticals Achieves Milestones with FDA Approval and Novartis Deal

Arrowhead Pharmaceuticals Achieves Milestones with FDA Approval and Novartis Deal

Arrowhead Pharmaceuticals Achieves Milestones with FDA Approval and Novartis Deal
Trendline Trendline
Edelson Lechtzin LLP Investigates CoreWeave for Potential Securities Violations

Edelson Lechtzin LLP Investigates CoreWeave for Potential Securities Violations

Edelson Lechtzin LLP Investigates CoreWeave for Potential Securities Violations
Trendline Trendline
Netflix's $72 Billion Acquisition of Warner Bros. Discovery Faces Regulatory and Market Challenges

Netflix's $72 Billion Acquisition of Warner Bros. Discovery Faces Regulatory and Market Challenges

Netflix's $72 Billion Acquisition of Warner Bros. Discovery Faces Regulatory and Market Challenges